» Articles » PMID: 22124344

Intravenously Transplanted Bone Marrow Stromal Cells Promote Recovery of Lower Urinary Tract Function in Rats with Complete Spinal Cord Injury

Overview
Journal Spinal Cord
Specialty Neurology
Date 2011 Nov 30
PMID 22124344
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: There is increasing evidence that intravenously injected neural progenitor cells promote recovery of bladder function in rodents, following contusive spinal cord injury through migrating into the injured spinal cord tissue and differentiating into central nervous system cells. The present study was aimed to clarify whether intravenously transplanted bone marrow stromal cells (BMSCs) could improve lower urinary tract (LUT) function in rats with spinal cord transection (SCT).

Methods: A total of 22 rats underwent experimentation in three groups, including group 1-sham operation, group 2 (BMSC)-SCT plus BrdU (5-bromo-2'-deoxyuridine) labeled BMSCs transplantation at day 9 after SCT, group 3-SCT control. All rats were investigated urodynamically on day 28 after transplantation.

Results: BMSCs identified by BrdU immunohistochemistry survived in the injured spinal cord and lumbar level 3-4 (L(3-4)). Voiding pressure, episodes of non-voiding contractions and residual urine volumes were significantly decreased in BMSC rats, compared with the controls. Bladder capacity was similar in both groups. In four out of eight BMSC rats and one out of seven controls, the tonic and bursting external urethral sphincter electromyographic activity were detected during cystometry. Silent periods during bursting were shorter and activity periods were longer in BMSC rats compared with sham rats.

Conclusion: Intravenously transplanted BMSCs survived in the L(3-4) and had beneficial effects on the recovery of LUT function in the rats after SCT.

Citing Articles

Stem Cell Therapy in Spinal Cord Injury-Induced Neurogenic Lower Urinary Tract Dysfunction.

Ou Y, Huang C, Kao Y, Ho P, Tsai K Stem Cell Rev Rep. 2023; 19(6):1691-1708.

PMID: 37115409 DOI: 10.1007/s12015-023-10547-9.


Considerations for the clinical use of stem cells in genitourinary regenerative medicine.

Caneparo C, Sorroza-Martinez L, Chabaud S, Fradette J, Bolduc S World J Stem Cells. 2021; 13(10):1480-1512.

PMID: 34786154 PMC: 8567446. DOI: 10.4252/wjsc.v13.i10.1480.


Glial restricted precursor cells in central nervous system disorders: Current applications and future perspectives.

Martins-Macedo J, Lepore A, Domingues H, Salgado A, Gomes E, Pinto L Glia. 2020; 69(3):513-531.

PMID: 33052610 PMC: 7857417. DOI: 10.1002/glia.23922.


Stem Cell Therapy for Neurogenic Bladder Dysfunction in Rodent Models: A Systematic Review.

Salehi-Pourmehr H, Hajebrahimi S, Rahbarghazi R, Pashazadeh F, Mahmoudi J, Maasoumi N Int Neurourol J. 2020; 24(3):241-257.

PMID: 33017895 PMC: 7538284. DOI: 10.5213/inj.2040058.029.


Effect of amniotic fluid stem cell transplantation on the recovery of bladder dysfunction in spinal cord-injured rats.

Liang C, Shaw S, Ko Y, Huang Y, Lee T Sci Rep. 2020; 10(1):10030.

PMID: 32572272 PMC: 7308393. DOI: 10.1038/s41598-020-67163-7.